Belvedere Trading’s Verona Pharma VRNA Stock Holding History

Belvedere Trading’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,100	Closed	-$1.61M	–	1098
2025 Q3	$1.61M	Buy	+15,100	New	+$1.58M	﹤0.01%	126
2023 Q1	–	Sell	-800	Closed	-$20.9K	–	1465
2022 Q4	$20.9K	Buy	+800	New	+$10.7K	﹤0.01%	814

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Belvedere Trading's VRNA Position: Q1 2023 in Review

Belvedere Trading sold out of Verona Pharma (VRNA) in Q1 2023, closing a stake of 8,686 shares — an estimated $227K sold.

Belvedere Trading first reported a position in VRNA in Q4 2022 and held it in 1 quarter. The position peaked at $227K in Q4 2022. 95 funds tracked by Wall St. Rank hold VRNA as of Q1 2023.

Belvedere Trading reported no remaining Verona Pharma position as of Q1 2023 after selling out during the quarter.
Belvedere Trading sold 8,686 Verona Pharma shares in Q1 2023, an estimated $227K.
Belvedere Trading first reported a position in Verona Pharma in Q4 2022 and held it in 1 quarter.
Belvedere Trading's Verona Pharma position peaked at $227K in Q4 2022.
95 funds tracked by Wall St. Rank held Verona Pharma as of Q1 2023.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.